RAND's divisions conduct research on a uniquely broad front for clients around the globe.
Most relevant regions
Research
Jan 1, 2003
Study to ascertain whether radical prostatectomy outcomes improved after the diffusion of surgical innovations during the last decade.
This study establishes a foundation on which to build quality-of-care assessment tools to evaluate the treatment of early-stage prostate cancer.
Physician support and prostate cancer screening knowledge were positively associated with previous screening.
Quality of life is of great concern to patients considering treatment options for prostate cancer.
The physical burden of prostate cancer is considerable and affects quality of life in men with both localized and metastatic disease.
These model-based lead-time estimates support a prostate cancer screening interval of more than 1 year.
Men diagnosed with metastatic prostate cancer during the follow-up after treatment for clinically localized disease report a better quality of life.
Jan 1, 2002
Patients dying of metastatic prostate cancer appear to experience declines in health-related quality of life during their final year of life.
Screening with normal PSA results is accompanied by a minimally to moderate deterioration of HRQOL in some subjects.
The mental health profiles differ for patients undergoing surgery, radiation, or watchful waiting for early stage prostate carcinoma.
Studies suggest ethnic or cultural difference in how impaired sexual function is integrated into overall QOL.
Jan 1, 2001
The authors examined changes in health related quality of life during the 12 months before death in men with prostate cancer.